Chromosome 7p15-p14 showed genome-wide significant linkage to asthma related traits among the Finnish and French-Canadian families. As an essential step toward cloning the susceptibility gene, a detailed physical map of the region is needed. In this study we report a dense set of carefully tested, new microsatellite markers for fine mapping embedded in a continuous, easy-to-read, physical map of the region that includes the known genes and putative transcripts. Even though susceptibility genes for asthma are difficult to predict from a multitude of unknown genes mapped to the region, TCRG encoding the g-chain of the heterodimeric g/d T cell receptor is a potential candidate. We present linkage and association results for TCRG in two independent Finnish family sets by using four highly polymorphic microsatellites spanning 169 kb across the locus. Linkage results confirmed our previous findings, but our study did not provide any evidence on behalf of a strong association of TCRG with either high serum total Immunoglobulin (IgE) level or asthma. Our results suggest that some other known or yet unidentified gene in the linkage region is the true asthma susceptibility gene.
Introduction
Recent genome wide scans have suggested several regions potentially linked to asthma and related traits. One of the loci of interest is located on 7p15-p14. Among Finnish asthma families, this locus was the only locus that reached genome wide significance level. 1 The finding was further confirmed among French-Canadian families and in another independent data set from Finland. 1 Daniels et al. 2 
have
reported six regions of possible linkage, including 7p14-p15, and established by simulations that at least some of them are likely to be true positives. German, 3 French, 4 and
Italian families 5 have shown some evidence of linkage, but there are also genome scans with inconclusive results, 6 -8 some of which have been done in ethnic populations other than Caucasian. 9, 10 Furthermore, clinically distinct autoimmune diseases may be controlled by a common set of susceptibility genes. 11 7p15-p14 has also been linked to diseases such as multiple sclerosis 12 and inflammatory bowel disease, 13 and genomic regions homologous to human 7p15-p14 have been linked to insulin dependent diabetes 14 and inflammatory arthritis 15 in rat models.
Implicating a susceptibility gene for such a complex disorder as asthma is difficult. As an essential step toward identifying a susceptibility gene for asthma, we need a detailed physical map of the linkage region that includes the known genes, putative transcripts, and genetic markers. In this study we report a continuous, easy-to-read, physical map of the region with structural and functional information of known genes. We also present our linkage and association results for TCRG among Finnish asthma families by using four highly polymorphic microsatellite markers within the TCRG locus. Our results suggest that TCRG is not significantly associated with asthma or high serum IgE level, and thus, TCRG might not be the major susceptibility gene for asthma in 7p15-p14.
Materials and methods

Construction of the physical map
We started the construction of a chromosome 7 physical map with the microsatellite markers found to be linked with high serum IgE level and asthma. 1 First, we used these markers to determine the corresponding region in the Radiation hybrid (RH) map (http://www.ncbi.nlm.nih.gov/genemap99), and to identify STSs, genes, ESTs, clones and contigs located in the region. Second, we used RH dist-ances of the STS, genes, and ESTs mapped into clones/contigs, and the order of clones/contigs in NBCI Human Chromosome 7 contig map (http://www.ncbi.nlm.nih.gov/genome/seq/chr.cgi?CHR=7 ) to roughly organise the clones and contigs. Third, to determine the exact order and orientation of clones and contigs, we explored public databases with different contig and clone end sequences, cDNA and EST sequences by BLAST. To fill in the gaps in public sequence, we also used the Celera database (http://public. celera.com/index.cfm). Fourth, we compared the organisation of our map to different genomic databases to make sure that no major discrepancies were present. The comparisons were done using the Human Genome Browser (http://genome.ucsc.edu/goldenPath/octTracks.html), the NCBI Entrez Genomes Database (http://www.ncbi.nlm.nih. gov/genome/seq/), the Sanger Center Ensemble Database (http://www.ensembl.org/), and the Celera database. During the process additional information was also collected from the NCBI databases (http://www.ncbi.nlm.nih.gov/index. html) UniSTS, UniGene, OMIM, LocusLink, and from the Marshfield Genetic Map (http://research.marshfieldclinic. org/genetics). Finally, cDNA sequences were used to map the exons of known genes in genomic sequence. The physical map was drawn based on collected data of clones, genes and markers using the PhysiMap program (http://www.ee. oulu.fi/*polvi/physimap.htm) developed specifically for this purpose.
Design of new microsatellite markers
To create a dense map of polymorphic markers spread evenly across the linkage region, we screened the publicly available genomic sequence for potentially polymorphic short sequence repeats. The repeats were initially tested by PCR amplification in 10 unrelated individuals. If allelic polymorphism was detected, the Mendelian inheritance was confirmed in 10 nuclear families. Detailed information on primers, PCR conditions and allele frequencies are available in the GenBank (http://www.ncbi.nlm.nih.gov/Genbank/) and at our www site (http://www.genome.helsinki.fi/ english/research/projects.xml).
Two independent family collections for linkage and association analysis First family recruitment was done in the Kainuu province in central eastern Finland in 1994 and 1996. The methods for recruitment, control for population stratification, and clinical evaluation have been described previously in detail. 16, 17 The second family collection was recruited from the province of North Karelia in southern eastern Finland in 1999. Like Kainuu, it represents the late settlement region of Finland, but with a distinct population history than that of the first data set, ie the settlers came from a different donor population. The study subjects were initially identified by a population survey. 1, 18 All participants were invited into a clinical trial to evaluate their history of atopic disorders (FinnAllergy study). Probands (n=791) were carefully studied clinically. Among the participants, there were 180 individuals with IgE level 4100 kU/l. They were contacted by a letter and asked to join a genetic study with their nuclear family members. Altogether 85 families and 517 individuals were recruited; 26 of the families were trios. In 69 families the proband reported atopic symptoms in multiple family members and other siblings. All participants filled out a questionnaire including questions of respiratory symptoms, smoking habits, medication and physician-made diagnosis of asthma or other atopic disorders. Total serum IgE level was determined by Diagnostics CAP FEIA (Kabi Pharmacia, Sweden) in both the Kainuu and North Karelia study groups.
Linkage and association analysis for TCRG TCRG was mapped to the genomic clones AC006033 and AC07245 using exon sequences for V1, V2, V3, V4, V5, V5P, V6, V7, V8, VA, V9, V10, VB, V11, JP1, JP, J1, C1, JP2, J2, and C2 retrieved from the international ImMunoGeneTics database (IMGT) (http://imgt.cines.fr:8104). 19 All polymorphic sites (TCR4, TCR6, and TCR7) and two flanking markers D7S2497 (heterozygosity 0.87) and MN35 were genotyped in both sample sets. For genotyping, DNA was extracted from blood leukocytes by a standard non-enzymatic method. The primer pairs were fluorescently labelled (Genosys, UK). PCR amplification was done separately for each marker and run pooled on an ABI377 sequencer. Linkage and association analyses were performed using GENEHUNTER 2.0 20 and
Haplotype Pattern Mining (HPM), 21 respectively.
For haplotyping, large pedigrees were divided into trios using an in-house computer programme. The programme identifies the maximal number of trios that are not overlapping and in which one or two members were affected (not both parents). Trios that included members who had not been genotyped or members with unknown phenotype were excluded. Haplotyping was done within each trio and four independent chromosomes were obtained from each trio. In case of ambiguities (missing genotype data, identical heterozygotic genotypes in all of the family members, or Mendel errors), data for that marker were discarded. If the child was TCRG and asthma A Polvi et al 659 affected, the transmitted chromosomes were considered disease associated and the non-transmitted chromosomes as controls. If one of the parents was affected, his/her chromosomes were considered disease associated and the spouse's chromosomes as controls. If both the parent and the child were affected, only the non-transmitted chromosome of an unaffected parent was considered as the control and the other three as disease associated. These haplotypes, labelled as disease-associated or control, were then used as input for HPM.
The HPM algorithm finds all the haplotype patterns up to a given length whose association to the trait, measured by a 262 w 2 -test, exceeds a given threshold value. To make the algorithm more robust with respect to marker mutations, genotyping errors, and missing data, a user-specified number of gaps is allowed in the patterns. Based on the found patterns, each marker is given a score based on the number of patterns spanning across the marker. HPM estimates the significances of the obtained scores against the null hypothesis that there is no association. The null distributions are estimated by permuting the trait values and recalculating the scores several times. Comparing the observed scores to these distributions yields marker-wise P values that are comparable with each other.
To estimate the overall significance of detected association, accounting simultaneous testing of multiple markers, we performed nested permutation tests. The lowest marker-wise P value is compared to the distribution of the lowest markerwise P values obtained when the HPM analysis is repeated several times with permuted data, yielding a corrected P value. The procedure has been described in detail (see www.acm.org/ sigkdd/kdd2001, and www.cs.helsinki.fi/TR/C.html).
22,23
Results
Physical map
The clones, contigs, genes and markers that are located on 7p15-p14 and linked to asthma are shown in Figure 1 . Altogether 184 clones were placed into the map. Nine gaps were detected between the following nine clones: After the assembly of the clones, we compared their order and orientation to the most complete draft assembly of the human genome (http://genome.cse.ucsc.edu/goldenPath/ octTracks.html). Draft sequence showed high concordance with our map. However, two major discrepancies were observed. First, NT_000369 showed reverse orientation in the draft sequence, but our assembly results could be confirmed by the Celera and Sanger Institute Ensemble databases. Second, seven clones in our map were absent in the corresponding region of the draft sequence. Five of the clones (AC087072.2, AC087069.2, AC078843.2, AC026866.8, and AC017116.5) could be found in the NCBI Entrez Genome Database placed between the same clones as in our map. In addition, AC015515.3 was shown to partially overlapping with AC027269.5, as in our map. The position of the clone AC087070.2 was confirmed from the Sanger Center Ensemble Database.
When we compared the comprehensive genetic map to our physical map (Figure 2) , the order for six markers (D7S1806, D7S1514, D7S668, D7S2469, D7S2548, and D7S678) differed. In 11 cases, two or more markers were mapped into the same genetic position, on our physical map the marker order could be now verified. Figures 1 and 2 are available in more detail at our web site (http://www.genome.helsinki.fi/eng/research/asthma/ pubs.html).
New microsatellite markers
We have carefully tested 53 new microsatellites for the region; 31 of them that were robust to type, polymorphic, and followed Mendelian inheritance in 10 families were chosen for an association study (http://www.genome.helsinki.fi/ eng/research/asthma/pubs.html). The intermarker distance for markers shown in the asthma linkage region (Figure 1 ) is on average 210 kb (range from 17 to 656 kb).
Genes in the region
Altogether 87 known and putative genes were identified in the region (please see http://www.genome.helsinki.fi/ eng/research/asthma/pubs.html for specific data). Most genes encode proteins with known structure or/and function, but also genes with only predicted protein product are included. The region includes one cluster of genes (HOXA1-13) belonging to a HOX-gene family while the remaining genes encode proteins that fall functionally and structurally into multiple categories.
TCRG linkage and association analysis
To study the role of TCRG as a potential candidate locus in asthma, we first screened altogether eight tandem repeats TCRG and asthma A Polvi et al 660 Figure 1 Physical map of the chromosome 7p15-p14 showing the organisation of exons of known genes and polymorphic genetic markers (above), and the organisation of genomic BAC clones and contigs (below). within the locus (Figure 3 ). Three of them (TCR4, TCR6, and TCR7) were confirmed to be highly polymorphic in 20 chromosomes tested and showed Mendelian inheritance in 10 nuclear families. These three markers and two flanking markers D7S2497 and NM35, spanning a 169 kb haplotype, were then genotyped in two Finnish family sets (1150 individuals). Later, however, TCR7 was excluded from the analysis, since sequencing of some individuals with ambiguous genotypes showed that even alleles of same size were actually different in sequence because of several SNPs within the repeat and single nucleotide insertions in a string of adenosines upstream of the repeat. The remaining markers showed strong linkage disequilibrium across the region when analysed in consecutive pairs by 262 contingency tables (P510 728 ).
Both linkage and haplotype association analyses were done for two phenotypes: asthma and high total serum IgE level, with new markers added. For comparison, exactly the same pedigrees were included into the non-parametric multipoint linkage analysis as in our genome scan. 17 For the TCRG markers, the best linkage was found to high IgE level when both data sets were pooled together (NPL score 3.3, P=0.0009, information content 0.86 at D7S2497) ( Table  1) . For asthma, NPL scores was 2.2 across TCRG (P=0.003, information content 0.80) in the Kainuu data set, among the North Karelia families asthma status was unknown. As expected, the overall linkage for 7p14-p15 was at the same level as before. 1 The best linkage hits were outside the TCRG locus; for IgE at D7S691 (NPL score 4.0, P=0.0001, information content 0.80) in the combined data set and for asthma in the Kainuu data set, at GATA31A10 (NPL score 2.7, P=0.004, information content 0.66). By using the HPM algorithm, 21 the best allele and haplotype associations for high IgE were found again in the combined data set. Altogether 596 chromosomes were retrieved from multiplex and nuclear families. Table 2 illustrates the best haplotype associations for high IgE level. All found associations remained rather weak (w 2 47.5). For asthma, the number of associated haplotypes and the strength of found associations remained even lower (Table 2) .
To study if the overall haplotype distribution in TCRG differs among the disease associated compared to control chromosomes, HPM analysis was done using the following parameters: maximum pattern length four markers, one gap allowed for missing data and possible errors, and w 2 threshold for the association 3.0. The observed scores (range from 6 to 22) (=number of qualified haplotype patterns spanning across the marker) for associated haplotypes remained low for both phenotypes even with this low threshold for association. Permutation test showed no TCRG and asthma A Polvi et al 662 statistically biased haplotype distribution for asthma (marker-wise P values 0.47 -0.76) and borderline significance for high IgE level (lowest marker-wise P value 0.038 at TCR6).
To evaluate the overall significance of this smallest marker-wise P value observed, it should be further corrected for multiple testing. Since most of the variables (tested markers and phenotypes) are highly correlated, a simple Bonferroni adjustment is obviously too conservative. To estimate the effect of simultaneous testing of multiple markers, we used a second level permutation test. 22, 23 The P value of 0.038 was compared to the distribution of the lowest marker-wise P values obtained when the HPM analysis was repeated several times with permuted data, yielding a corrected P value of 0.059. Previously we have estimated by simulations that a correction of 1.3 should be used for the two correlated phenotypes, 1 yielding a final P value of 0.08. Total, the number of chromosomes in which the number of missing alleles within the pattern does not exceed 30%; All, the number of haplotypes with a specific pattern; Asthma/high IgE, the number of disease associated haplotypes with the specific pattern; Confidence, percentage of haplotypes with the specific pattern that are associated with the disease, w 2 , value for disease association of the specific haplotype pattern.
TCRG and asthma
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Discussion
Chromosome 7p14-p15 has been linked to asthma related traits in Finnish, French-Canadian, and Australian populations 1,2 and to other immune mediated disorders. 11 For positional cloning projects, an accurate physical map is crucial. Although several maps of the region are publicly available, none of them includes all information and discrepancies exist. Based on our calculations in the Finnish data, the appropriate confidence region for positional cloning of the susceptibility gene for asthma is from the marker D7S526 to D7S1830 (24 cM). 24 Our *20 Mb physical map covers most of the region with 184 genomic clones and 87 genes. Only information that could be verified from several sources is indicated on the map. Fifty-three new markers were added to 50 previously published markers. They form a highly informative marker map across the region with an average marker density of 210 kb. With a couple of exceptions, physical distances between the markers matched well with the genetic distances (1 cM*1 Mb), but the more precise map allowed us to order the markers correctly ( Figure 2 ). As a potentially interesting candidate, TCRG has been mapped to this region. 25 TCRG (*130 kb) consists of a cluster of 14 highly polymorphic variable (V1-V11, V5P, VA and VB, including five pseudogenes), five joining (JP1, JP, J1, JP2, and J2), and two constant genes (C1 and C2) that are rearranged during g/d T cell differentiation to encode gchain of the heterodimeric T cell receptor 19, 26 ( Figure 3 ). 
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Because the germline sequence of the TCRG locus consists of highly homologues elements, genotyping of single nucleotide polymorphisms described in different T cell clones can be extremely difficult. 20 We chose to apply in our linkage analysis four highly polymorphic and stable microsatellite markers. Our analysis showed that TCRG is definitively located within the linkage peak that we have reported previously, but the observed NPL scores did not exceed that of the neighbouring markers. Our study did not provide any evidence for a strong association of TCRG with either high serum total IgE level or asthma. All found associations were weak and distributed in multiple, rare TCRG haplotypes. Since asthma is a complex disorder with interactions of many cell types and tissues, it is very difficult to exclude any of the genes of the region. As a new working hypothesis, we must consider the possibility that some other known or yet unidentified genes in the linkage region will show a stronger association to asthma.
